General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Akero Therapeutics ×
Akero Therapeutics is a clinical stage biotechnology company developing novel therapies for patients with non-alcoholic steatohepatitis (NASH).